Getting Your Mandibular Advancement Splint at Smile Solutions Melbourne: A Step-by-Step Patient Guide product guide
Getting Your Mandibular Advancement Splint at Smile Solutions Melbourne: A Step-by-Step Patient Guide
Starting treatment for snoring, obstructive sleep apnoea (OSA), or bruxism-related jaw pain can feel overwhelming - especially when the pathway from symptom to solution is unclear. For many patients at Smile Solutions Melbourne, the mandibular advancement splint (MAS) represents the most effective, non-invasive step toward better sleep and a healthier jaw. Yet the single most common reason patients delay or abandon MAS treatment is not cost or discomfort - it is uncertainty about the process itself.
This guide removes that uncertainty entirely. What follows is a detailed, stage-by-stage account of what to expect at every appointment, what happens between visits, and how you'll know the treatment is working. Understanding the journey transforms a passive patient into an active participant - and active participation is one of the strongest predictors of treatment success.
Why the Patient Journey Matters as Much as the Device
Mandibular advancement splint therapy is the leading alternative to CPAP therapy for the treatment of obstructive sleep apnoea. A MAS is an oral appliance which advances the mandible in relation to the maxilla, thus increasing airway calibre and reducing collapsibility. But the device itself is only part of the equation.
A specialised dentist in the field should be responsible for insertion of the device and follow-up of patients, and gradual titration of the mandible is extremely important to improve MAS efficacy. This is precisely why the Smile Solutions approach is structured as a multi-stage clinical journey rather than a single-visit prescription - the process is the therapy.
The best retention, comfort, and efficacy are achieved with custom-made, titratable oral appliances. Off-the-shelf devices, by contrast, cannot replicate the precision fit and adjustability that determine whether a patient achieves a therapeutic outcome or abandons treatment within weeks.
Stage 1: Initial Consultation and Integrated Airway/TMJ Assessment
What Happens at Your First Appointment
Your first appointment at Smile Solutions is not simply a "dental check" - it is a structured clinical assessment that evaluates three interconnected systems: your airway anatomy, your temporomandibular joints (TMJ), and your dentition. This integrated approach reflects the evidence that TMD, bruxism, and OSA frequently coexist and must be assessed together before any device is fabricated (see our guide on The TMD–Bruxism–Sleep Apnoea Connection: How Jaw, Teeth, and Airway Problems Are Linked).
The assessment typically includes:
Medical and sleep history review - including any prior sleep studies, CPAP trials, and reported symptoms (snoring, witnessed apnoeas, morning headaches, jaw pain, tooth wear)
TMJ and jaw examination - assessing range of motion, joint sounds, muscle tenderness, and signs of bruxism-related wear
Airway screening - evaluation of neck circumference, tongue position, tonsil size, and jaw retrognathia
Maximum mandibular protrusion measurement - a critical step, as the maximum mandible advancement capability should be ≥ 5 mm in order to achieve optimal MAS efficacy.
Dental health assessment - checking for adequate tooth structure, periodontal health, and any contraindications to MAS wear
Why Pre-Treatment Sleep Testing Is Non-Negotiable
Pre-treatment evaluations such as polysomnography and upper airway examinations are essential to establish an accurate diagnosis and guide therapeutic decisions. At Smile Solutions, patients who have not yet undergone a diagnostic sleep study are referred to a sleep physician or arranged for home sleep testing before a MAS is fabricated. This is not a bureaucratic hurdle - it is a clinical safeguard.
Without a confirmed diagnosis, there is no objective baseline against which to measure treatment success. More critically, a patient with undiagnosed severe OSA needs a different management pathway than one with primary snoring or mild-to-moderate disease (see our guide on How TMD, Bruxism, and Sleep Apnoea Are Diagnosed: From Clinical Exam to Sleep Study).
The joint AASM/AADSM clinical practice guideline recommends oral appliance therapy as an effective treatment for primary snoring in adults; however, because snoring is a cardinal symptom of OSA, a diagnosis of primary snoring should be rendered by a sleep physician prior to treatment initiation.
Stage 2: Dental Impressions and CAD/CAM Device Fabrication
Taking the Bite Registration: Precision Is Everything
Once candidacy is confirmed, the next appointment focuses on capturing the precise anatomical data needed to fabricate your device. This involves:
- Intraoral scanning or physical impressions of the upper and lower dental arches
- Bite registration at a therapeutic mandibular position - typically set at approximately 50–75% of your maximum protrusive range
According to the available evidence, clinicians should take the bite registration with the mandibular advancement set at least to 50% followed by a graduated titration protocol to reach the most tolerated therapeutic (advanced) position of the mandible.
The precision of this step directly determines device comfort and initial efficacy. The more precise the impressions, the more comfortable the MAS will be for the patient. If an impression is damaged, inadequate, or inaccurate, the MAS will not provide proper fit and retention.
The CAD/CAM and 3D-Printed Nylon Advantage
Smile Solutions utilises CAD/CAM technology and 3D-printed nylon fabrication - a significant clinical advancement over traditional acrylic devices. Advancements in technology now allow for the creation of digital impressions and the development of virtual dental models, which can be accurately transferred to a virtual articulator. This process utilises computer-aided design/computer-aided manufacturing (CAD/CAM), 3D scanning, and additive manufacturing technologies to enhance efficiency and precision.
Compared to conventional prefabricated appliances, 3D-printed devices provide better airway support, more precise jaw guidance, and greater long-term comfort. CAD-based modelling and digital intraoral scanning improve occlusal precision, guarantee consistency across various anatomical profiles, and allow for precise control of advancement levels.
MADs are used to treat obstructive sleep apnoea and typically require 8–10 days to fabricate as per the patient's specifications. The currently designed digital methodology considerably shortens this timescale to 2–3 days, providing a viable alternative to traditional methods.
Patients can expect to receive their finished device within approximately one to two weeks of the impression appointment.
Stage 3: The Fitting Appointment - Your First Experience with the Device
What Happens When You Receive Your MAS
The fitting appointment is where the device first enters the clinical picture - and where patient education becomes paramount. At the time of delivery, the clinician must verify the individual fit and comfort of each splint, ensuring they can be inserted and removed without discomfort. Insertion follows a defined sequence: the maxillary splint is positioned first, followed by the mandibular splint, which is guided into place by its lateral wings.
At this appointment, your Smile Solutions clinician will:
- Verify the fit and retention of both upper and lower components
- Check that no individual teeth are under excessive pressure
- Teach you the correct insertion and removal technique
- Demonstrate how to operate the titration mechanism
- Provide written care instructions
Managing Normal First-Night Expectations
Patients should be reassured regarding common initial adaptation symptoms - such as tightness, mild discomfort, articular pain, or excessive salivation - and should be encouraged to wear the device consistently. These sensations are expected and typically resolve within the first one to two weeks as your jaw muscles and TMJ adapt.
Maintenance instructions include daily cleaning with a denture brush and neutral soap, air drying, and weekly disinfection with a product recommended by the manufacturer.
Patients are advised to wear the device every night from the outset. Intermittent use during the adaptation phase prolongs discomfort and delays titration.
Stage 4: Titration - Finding Your Therapeutic Position
What Is Titration and Why Does It Take Time?
Titration is the gradual, incremental advancement of the mandible toward its optimal therapeutic position. It is not a single event - it is an ongoing clinical process that typically unfolds over six to twelve weeks.
Titration should only begin once the patient is able to wear the device comfortably and pain-free throughout the entire night. In the absence of contraindications, an initial mandibular advancement of 1 mm is typically recommended. Each subsequent adjustment should be spaced 2 to 3 weeks apart to allow for neuromuscular and temporomandibular joint (TMJ) adaptation.
Titration generally begins 2 to 3 weeks after delivery, once the device is well tolerated throughout the night.
How Much Advancement Is Needed?
Optimal titration is important to maximise the therapeutic benefits of the MAS device. An advancement of at least 50% of maximum mandibular protrusion is required to have a potential therapeutic outcome while minimising adverse side effects.
Because the patient's tolerance to the amount of protrusion increases over time, splints capable of incremental advancement seem to have a clear practical advantage. These adjustable devices also facilitate improved efficacy as they can be titrated to a more optimal setting needed to ablate obstructive events.
What to Watch For During Titration
Your titration progress will be guided by two parallel streams of feedback:
- Subjective reporting - reduction in snoring (often confirmed by a bed partner), improvement in sleep quality, reduced morning fatigue, and decreased jaw soreness
- Objective monitoring - in some cases, home oximetry can track oxygen desaturation trends between titration visits
Excessive mandibular advancement, while it can further enlarge the volume of the upper airways, may also exacerbate side effects such as temporomandibular joint (TMJ) pain and muscle fatigue upon awakening. If these symptoms emerge, your clinician will reduce the advancement increment and allow additional adaptation time. This is normal clinical management, not a sign of treatment failure.
Stage 5: Follow-Up Sleep Testing to Confirm Efficacy
Why a Post-Titration Sleep Study Is Clinically Essential
Once your device has been titrated to a stable, comfortable position - typically after six to twelve weeks - a follow-up sleep study is performed with the MAS in place. This is not optional: it is the only way to objectively confirm that the device is working at a therapeutic level.
International guidelines recommend a progress diagnostic sleep study following titration to assess the efficacy of the device (Ramar et al., 2015).
A follow-up sleep study is recommended to confirm MAS efficacy.
The follow-up study - which may be conducted as an in-lab polysomnography or a validated home sleep test - measures whether your AHI (Apnoea–Hypopnoea Index) has been reduced to a clinically acceptable threshold.
What Does Clinical Success Look Like?
Subjective improvements with MAS were reported by the majority of patients (96%). There were significant improvements in AHI, minimum oxygen saturation, and arousal index with MAS compared with the control.
In a randomised controlled trial published in the American Journal of Respiratory and Critical Care Medicine (Gotsopoulos et al., 2002), the MAS resulted in a significant reduction in AHI (by 53%), arousal index (by 34%), mean snoring frequency (by 47%), and mean intensity (by 3dB), compared with the control plate.
Across multiple clinical cohorts, MAD therapy was associated with clinically meaningful improvements across multiple outcome measures, with reductions in the Apnoea–Hypopnoea Index from baseline observed in the majority of cohorts.
If the follow-up study shows residual apnoeas, your clinician can advance the device further - provided there is remaining protrusion range - or refer for collaborative review with a sleep physician regarding combination therapy.
Stage 6: Long-Term Monitoring and Maintenance
Annual Review Appointments
MAS therapy is not a "fit and forget" intervention. Annual review appointments at Smile Solutions are essential for:
- Occlusal monitoring - tracking any progressive changes in bite relationship
- Device inspection - checking for wear, fractures, or loss of retention
- Symptom reassessment - confirming ongoing efficacy, particularly if weight changes, nasal obstruction, or new medications have altered your airway physiology
- Device replacement planning - MAS devices typically require replacement every three to five years depending on material and wear patterns
MAD treatment remained effective over 5-year follow-up in patients with mild to severe OSA who were intolerant of, noncompliant with, or refused CPAP. Despite a slight worsening of respiratory parameters over time, sleepiness and symptoms such as fatigue and morning headache remained well controlled, and sleep quality showed marked and sustained improvements during long-term MAD therapy.
Understanding Long-Term Occlusal Changes
Patients committing to long-term MAS therapy should be aware of the evidence on progressive dental changes. A landmark retrospective study by Pliska et al. (2014) published in the Journal of Clinical Sleep Medicine followed 77 patients over an average treatment length of 11.1 years. Over the total treatment interval, there was a significant reduction in overbite (2.3 ± 1.6 mm), overjet (1.9 ± 1.9 mm), and mandibular crowding (1.3 ± 1.8 mm).
These changes are manageable and predictable when monitored regularly - but they underscore why annual dental reviews are not optional. (For a full discussion of long-term side effects, see our guide on Long-Term Care and Side Effects of Mandibular Advancement Splints: What Every Patient Should Know.)
Your Complete MAS Journey at a Glance
| Stage | Appointment | Timeframe | Key Outcome |
|---|---|---|---|
| 1 | Initial consultation + airway/TMJ assessment | Week 1 | Candidacy confirmed; sleep study arranged if needed |
| 2 | Impressions + bite registration | Week 2–3 | Data captured for CAD/CAM fabrication |
| 3 | Device fitting | Week 4–5 | MAS delivered; insertion/removal taught |
| 4 | Titration (multiple reviews) | Weeks 6–16 | Mandible advanced incrementally to therapeutic position |
| 5 | Follow-up sleep study | Weeks 12–20 | Objective AHI reduction confirmed |
| 6 | Annual review | Ongoing | Occlusal monitoring; device maintenance; efficacy reassessment |
Key Takeaways
- The MAS journey at Smile Solutions is a structured, multi-stage clinical process - not a single-visit prescription. Each stage serves a specific diagnostic or therapeutic purpose, and skipping stages compromises outcomes.
- Pre-treatment sleep testing establishes the baseline against which treatment success is measured. Without it, there is no way to know whether the device is working at a clinically meaningful level.
- CAD/CAM and 3D-printed nylon fabrication deliver superior precision, fit, and durability compared to traditional acrylic devices, improving both comfort and long-term adherence.
- Titration is gradual and patient-driven - incremental advancements of approximately 1 mm, spaced 2–3 weeks apart, allow the jaw and TMJ to adapt without triggering pain or early discontinuation.
- International guidelines recommend a follow-up sleep study post-titration to confirm objective efficacy. Subjective improvement alone is insufficient to verify treatment success.
Conclusion
Getting a mandibular advancement splint is not a passive experience - it is a collaborative clinical journey that unfolds over several months and requires active engagement at every stage. From the initial airway and TMJ assessment through to long-term annual monitoring, each step in the Smile Solutions pathway is grounded in the best available clinical evidence and designed to maximise your individual therapeutic outcome.
For patients with snoring, mild-to-moderate OSA, or bruxism-related jaw symptoms, this journey represents one of the most effective and tolerable treatment pathways available. Understanding what lies ahead - and why each step matters - is the first and most important move toward better sleep.
To build a complete picture of your condition before your first appointment, explore our related guides: Recognising the Signs: When Jaw Pain, Headaches, Snoring, and Grinding Mean You Need Assessment; Mandibular Advancement Splints Explained: How They Work, Who They're For, and What to Expect; and Why Choose Smile Solutions Melbourne for TMD, Bruxism, and Sleep Apnoea Treatment?
Smile Solutions has been providing dental care from Melbourne's CBD since 1993. Located at the Manchester Unity Building, Level 1 and 10, 220 Collins Street, Smile Solutions brings together 60+ clinicians - including 25+ board-registered specialists - who have cared for over 250,000 patients. No referral is required to book a specialist appointment. Call 13 13 96 or visit smilesolutions.com.au to arrange your TMD and sleep treatment consultation.
References
Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD. "Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015." Journal of Clinical Sleep Medicine, 2015;11(7):773–827. https://doi.org/10.5664/jcsm.4858
Pliska BT, Nam H, Chen H, Lowe AA, Almeida FR. "Obstructive Sleep Apnea and Mandibular Advancement Splints: Occlusal Effects and Progression of Changes Associated with a Decade of Treatment." Journal of Clinical Sleep Medicine, 2014;10(12):1285–1291. https://doi.org/10.5664/jcsm.4278
Gotsopoulos H, Chen C, Qian J, Cistulli PA. "A Randomized, Controlled Study of a Mandibular Advancement Splint for Obstructive Sleep Apnea." American Journal of Respiratory and Critical Care Medicine, 2002;163(6):1457–1461. https://doi.org/10.1164/ajrccm.163.6.2004213
Attali V, et al. (ORCADES Study Investigators). "Mandibular Advancement Device Use in Obstructive Sleep Apnea: ORCADES Study 5-Year Follow-Up Data." Journal of Clinical Sleep Medicine, 2021. https://doi.org/10.5664/jcsm.9308
Almeida FR, Mulgrew A, Ayas N, et al. "Mandibular Advancement Splint as Short-Term Alternative Treatment in Patients with Obstructive Sleep Apnea Already Effectively Treated with Continuous Positive Airway Pressure." Journal of Clinical Sleep Medicine, 2013;9(4):319–324. https://doi.org/10.5664/jcsm.2576
Piskin B, Uyar A, Yuceer M, et al. "Fabrication of a Mandibular Advancement Device Using a Fully Digital Workflow: A Clinical Report." Journal of Prosthodontics, 2021;30(3):191–195. https://doi.org/10.1111/jopr.13297
Desrentes E, et al. "Step-by-Step Clinical Protocol for the Fabrication and Titration of a Bibloc Mandibular Advancement Device: A Practical Guide for Sleep Physicians." Sleep and Breathing, 2025. https://doi.org/10.1007/s11325-025-03514-w
Alrobayan A, et al. "Efficacy of Mandibular Advancement Devices in the Treatment of Mild to Moderate Obstructive Sleep Apnea: A Systematic Review." MDPI Dentistry Journal, 2025;5(4):49. https://doi.org/10.3390/dj5040049
Gauthier L, et al. "Mandibular Advancement Splint Titration in Obstructive Sleep Apnoea." PubMed / Sleep Medicine, 2009. PMID: 18989715
Sutherland K, et al. "Innovations in Mandibular Advancement Splint Therapy for Obstructive Sleep Apnoea." Frontiers in Sleep, 2023. https://doi.org/10.3389/frsle.2023.1144327